TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells
- PMID: 20526283
- PMCID: PMC2905255
- DOI: 10.1038/emboj.2010.94
TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells
Abstract
Skin cancers are the most commonly diagnosed cancers. Understanding what are the factors contributing to skin tumour development can be instrumental to identify preventive therapies. The myeloid differentiation primary response gene (MyD)88, the downstream adaptor protein of most Toll-like receptors (TLR), has been shown to be involved in several mouse tumourigenesis models. We show here that TLR4, but not TLR2 or TLR9, is upstream of MyD88 in skin tumourigenesis. TLR4 triggering is not dependent on lipopolysaccharide associated to skin-colonizing bacteria, but on the high mobility group box-1 protein (HMGB1), an endogenous ligand of TLR4. HMGB1 is released by necrotic keratinocytes and is required for the recruitment of inflammatory cells and for the initiation of inflammation. The expression of TLR4 on both bone marrow-derived and radioresistant cells is necessary for carcinogenesis. Consistently, a human tissue microarray analysis showed that melanoma and colon cancer display an over-expression of TLR4 and its downstream adaptor protein MyD88 within tumours. Together, our results suggest that the initial release of HMGB1 triggers a TLR4-dependent inflammatory response that leads to tumour development.
Conflict of interest statement
The authors declare that they have no conflict of interest. However, ME Bianchi is founder and part owner of HMGBiotech, a company that provides goods and services related to HMGB proteins.
Figures
Similar articles
-
HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2579-93. doi: 10.1161/ATVBAHA.115.305789. Epub 2015 Oct 29. Arterioscler Thromb Vasc Biol. 2015. PMID: 26515416 Free PMC article.
-
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.Shock. 2006 Aug;26(2):174-9. doi: 10.1097/01.shk.0000225404.51320.82. Shock. 2006. PMID: 16878026
-
Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.J Immunol. 2004 May 15;172(10):6345-53. doi: 10.4049/jimmunol.172.10.6345. J Immunol. 2004. PMID: 15128825
-
[The Immunosuppressive Function of Myeloid-derived Suppressor Cells Is Regulated by the HMGB1-TLR4 Axis].Yakugaku Zasshi. 2018;138(2):143-148. doi: 10.1248/yakushi.17-00158. Yakugaku Zasshi. 2018. PMID: 29386427 Review. Japanese.
-
TLR4-directed Molecular Strategies Targeting Skin Photodamage and Carcinogenesis.Curr Med Chem. 2018;25(40):5487-5502. doi: 10.2174/0929867324666170828125328. Curr Med Chem. 2018. PMID: 28847267 Review.
Cited by
-
Unraveling the intricate relationship: Influence of microbiome on the host immune system in carcinogenesis.Cancer Rep (Hoboken). 2023 Nov;6(11):e1892. doi: 10.1002/cnr2.1892. Epub 2023 Sep 14. Cancer Rep (Hoboken). 2023. PMID: 37706437 Free PMC article. Review.
-
Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer.Int J Mol Sci. 2023 Jul 20;24(14):11695. doi: 10.3390/ijms241411695. Int J Mol Sci. 2023. PMID: 37511453 Free PMC article. Review.
-
The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.Oncol Rep. 2023 Aug;50(2):148. doi: 10.3892/or.2023.8585. Epub 2023 Jun 16. Oncol Rep. 2023. PMID: 37326109 Free PMC article.
-
Role of the Microbiome in Malignancy.Surg Infect (Larchmt). 2023 Apr;24(3):271-275. doi: 10.1089/sur.2023.028. Surg Infect (Larchmt). 2023. PMID: 37010971
-
The Formation of NETs and Their Mechanism of Promoting Tumor Metastasis.J Oncol. 2023 Mar 11;2023:7022337. doi: 10.1155/2023/7022337. eCollection 2023. J Oncol. 2023. PMID: 36942262 Free PMC article. Review.
References
-
- Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger S, Kaya Z, Buss S, Autschbach F, Pleger ST, Lukic IK, Bea F, Hardt SE, Humpert PM, Bianchi ME, Mairbaurl H, Nawroth PP, Remppis A, Katus HA, Bierhaus A (2008) High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation 117: 3216–3226 - PubMed
-
- Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, Andre F, Tursz T, Kroemer G, Zitvogel L (2007) The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 220: 47–59 - PubMed
-
- Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7: 211–217 - PubMed
-
- Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539–545 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
